Monoclonal Drug Therapy to Treat COVID-19 Available at Mountainside Medical Center
Mountainside Medical Center is offering monoclonal antibody treatment [Regen-Cov] to patients with confirmed COVID-19. The use of monoclonal antibody treatment has been shown to reduce the risk of hospitalization and death.
Those who qualify for monoclonal antibody treatment include:
· Individuals, 12 years and older weighing at least 88 pounds, with confirmed COVID-19 who are at risk of progressing to severe COVID-19 (including those who are 65 years of age or older, those with certain chronic medical conditions and those who are unvaccinated).
Read More